STAT

OCTOBER 4, 2024

Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S. government official confirmed on Friday.

Vaccines 363

Vaccines 363

STAT

FEBRUARY 12, 2024

A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. Read the rest…

Vaccines 363

Vaccines 363

STAT

FEBRUARY 27, 2024

An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. Those numbers will almost certainly rise amid the worst vaccine shortage since an oral vaccine was introduced in the 1990s.

Vaccines 359

Vaccines 359

STAT

MAY 10, 2024

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.     The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot.

Vaccines 363

Vaccines 363

STAT

OCTOBER 3, 2023

The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option. based company, which has struggled to claim a share of the now dwindling Covid vaccine market — globally and within the United States.

Vaccines 363

Vaccines 363

STAT

MARCH 25, 2024

A key factor in taming the pandemic was the creation of effective vaccines , which have saved millions of lives. You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. Merck, which saw its vaccine efforts fail twice, is up 56%.

Vaccines 357

Vaccines 357

STAT

SEPTEMBER 6, 2022

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research. Right now, Pfizer isn’t sharing its vaccines for research purposes, a spokesperson confirmed to STAT. Read the rest…

Vaccines 363

Vaccines 363

STAT

JULY 2, 2024

Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company announced in a statement Tuesday. Read the rest…

Vaccines 325

Vaccines Dosage 325

STAT

OCTOBER 13, 2023

6 months and older receive an updated Covid vaccine targeting the XBB.1.5 Since then, some notable voices, including Paul Offit , have publicly questioned whether the updated vaccine is needed for those who are not in a high-risk group. Last month, the Centers for Disease Control and Prevention recommended that everyone in the U.S.

Vaccines 364

Vaccines 364

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. The promise has long been an affordable, personalized cancer vaccine that could train the immune system to recognize proteins from cancer cells and, subsequently, destroy the tumor.

Vaccines 363

Vaccines Immunity Immunization Drug Development 363

STAT

AUGUST 16, 2024

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply. Read the rest…

Vaccines 361

Vaccines 361

STAT

JANUARY 21, 2024

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

JUNE 7, 2024

The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50. Arexvy, which was the first RSV vaccine approved , now becomes the first to be available to adults under the age of 60 who are not pregnant.

Vaccines 354

Vaccines 354

STAT

OCTOBER 24, 2023

People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. FluMist is only licensed for use in children and adults from the age of 2 to 49 years old. Read the rest…

Vaccines 363

Vaccines 363

STAT

SEPTEMBER 20, 2024

The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration.    Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so. 

Vaccines 359

Vaccines 359

STAT

FEBRUARY 28, 2024

has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. LONDON — Facing a growing outbreak of measles, the U.K.

Immunization 352

Immunization Immunity Vaccines 352

STAT

SEPTEMBER 26, 2023

The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021.

Vaccines 363

Vaccines 363

STAT

JANUARY 12, 2023

kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S.

Vaccines 363

Vaccines 363

STAT

DECEMBER 6, 2023

A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in Harare, Zimbabwe. The trial, known as PrEPVacc, was testing two different vaccine regimens on about 1,500 volunteers in East and Southern Africa.   Read the rest…

Vaccines 360

Vaccines Drug Development 360

STAT

JUNE 5, 2024

LONDON — Finland is preparing to offer vaccines to people at risk of exposure to an avian influenza strain spreading among farmed and wild animals, health officials there said, potentially becoming the first country to take such a step as concerns about the threat the virus poses to people intensify.

Vaccines 364

Vaccines 364

STAT

NOVEMBER 8, 2023

Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). The study randomly divided them into three groups based on their cities’ HPV vaccination strategies: gender-neutral HPV vaccination, girls-only vaccination, and no vaccination.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

FEBRUARY 22, 2024

A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease.

Vaccines 363

Vaccines 363

STAT

JANUARY 22, 2024

America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine. 6, a mere 21.5% 6, a mere 21.5% Read the rest…

Vaccines 363

Vaccines 363

STAT

MAY 9, 2024

Weeks after the global public health community sounded the alarm on the shortage of cholera vaccine, the World Health Organization moved to prequalify a new cholera vaccine last month. The vaccine is a simplified version of the two existing oral vaccines, both produced by Korean vaccine manufacturer EuBiologics Co.

Vaccines 325

Vaccines 325

STAT

JULY 29, 2024

A network of nascent vaccine manufacturers in low- and middle-income countries will soon start preliminary work to develop messenger RNA vaccines targeting the H5N1 bird flu virus, an effort that could speed production during a pandemic, should this virus trigger one.

Vaccines 362

Vaccines 362

STAT

JUNE 14, 2024

Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox.

Vaccines 315

Vaccines Immunity Immunization 315

STAT

OCTOBER 5, 2023

The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline. Read the rest…

Vaccines 348

Vaccines 348

STAT

SEPTEMBER 4, 2024

The emergence of a second mpox outbreak in which the virus is spreading from person-to-person, as well as a sharp increase in overall cases of the disease in several African countries, is straining the world’s capacity to make and distribute vaccine to battle the threat. Read the rest…

Vaccines 330

Vaccines 330

STAT

FEBRUARY 15, 2024

The Department of Health and Human Services announced Thursday that it is filling eight vacancies, including the chairmanship, on an important advisory panel on vaccine policy that was down to less than half of its normal roster for months.

Vaccines 325

Vaccines Immunity Immunization 325

STAT

AUGUST 22, 2024

regulators approved  updated Covid-19 vaccines  on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. manufacturer, Novavax, expects its updated vaccine version to be available a little later. WASHINGTON — U.S. A third U.S.

Vaccines 348

Vaccines 348

STAT

JULY 17, 2024

Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. Read the rest…

Vaccines 364

Vaccines 364

STAT

SEPTEMBER 29, 2022

A clinical trial of one or perhaps two experimental vaccines designed to protect against the Ebola Sudan virus could soon begin in Uganda, as long as the country agrees to allow the research to take place, an official of the World Health Organization said Wednesday. Read the rest…

Vaccines 346

Vaccines 346

STAT

AUGUST 14, 2024

In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It was as if an audible dog whistle began blaring right next to me.

Vaccines 363

Vaccines 363

STAT

DECEMBER 13, 2022

An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant Merck reduced the risk that melanoma would return after surgery or that patients would die by 44%, the company said.

Vaccines 344

Vaccines 344

STAT

OCTOBER 29, 2024

Vaccines are the original immunotherapy, in the view of Ryan Sullivan, a cancer immunotherapy researcher and oncologist at Mass General Cancer Center. Shadowed by the successes of other therapies, the field of cancer vaccines was “seemingly dying,” Sullivan said. Continue to STAT+ to read the full story…

Vaccines 349

Vaccines Immunity Immunization Drug Development 349

STAT

FEBRUARY 8, 2024

vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. A critical government advisory committee charged with charting U.S.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

JUNE 10, 2024

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses. Continue to STAT+ to read the full story…

Immunization 338

Immunization Immunity Vaccines 338